Loengard Anna U's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Aug 14, 2025
- Accession no.
- 0001801170-25-000221
- Filed
- Aug 14, 2025
- Trade date
- Aug 13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $68.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loengard Anna UCIK 0001952723 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Class A Common Stock | PPurchaseAcquired | +12,000 | $2.60 | +$31,200 | 27,600 | Indirect | |
| Aug 13, 2025 | Class A Common Stock | PPurchaseAcquired | +14,500 | $2.59 | +$37,555 | 29,610 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.